News By Tag
News By Place
Developing Proactive Pharmacovigilance and Risk Management Strategies
Top Pharmaceutical and Biotech Representatives to Discuss the Current Complexities and Key Challenges in Pharmacovigilance, May 6-7, 2014 in Philadelphia, PA
The meeting will address many pressing concerns regarding drug safety, including effectively identifying and managing potential risks and ensuring a balanced benefit-risk ratio. Top pharmaceutical and biotech representatives will discuss the current complexities and key challenges in pharmacovigilance and risk management throughout the product lifecycle.
Featuring Case Studies from Leading Pharmacovigilance Experts, including:
Katie Clifford, MBA, BSN, RN, Director, Drug Safety & Public Health, Gilead Sciences
Greg Pawell, Assistant Director, Medical Safety Evaluation, AbbVie
Jennifer Reinert, Senior Manager, Risk Management, Pfizer
Muneet Burke, MD, Director, Global Medical Safety, Janssen, Pharmaceutical Companies of Johnson and Johnson
Hot topics, such as the use of social media in signal detection and the role of pharmacovigilance across the product lifecycle will be discussed as well. In addition, attendees will have the opportunity to engage in meaningful conversations with their peers who are dealing with many of the same issues involved with pharmacovigilance, risk management, and adverse event reporting.
For more information on this conference & to get a complete list of speakers or sessions, click on the conference brochure (http://www.marcusevans-
About marcus evans
marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision-makers. Our global reach is utilized to attract over 30,000 speakers annually, ensuring niche focused subject matter presented directly by practitioners and a diversity of information to assist our clients in adopting best practice in all business disciplines.